These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37273001)

  • 21. Claustrum sign in a child with refractory status epilepticus after febrile illness: why does it happen?
    Silva G; Jacob S; Melo C; Alves D; Costa D
    Acta Neurol Belg; 2018 Jun; 118(2):303-305. PubMed ID: 28741106
    [No Abstract]   [Full Text] [Related]  

  • 22. Whole-exome and HLA sequencing in Febrile infection-related epilepsy syndrome.
    Helbig I; Barcia G; Pendziwiat M; Ganesan S; Mueller SH; Helbig KL; Vaidiswaran P; Xian J; Galer PD; Afawi Z; Specchio N; Kluger G; Kuhlenbäumer G; Appenzeller S; Wittig M; Kramer U; van Baalen A; Nabbout R;
    Ann Clin Transl Neurol; 2020 Aug; 7(8):1429-1435. PubMed ID: 32666661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multifocal multilobar focal cortical dysplasia type IIa in Febrile Infection Related Epilepsy Syndrome (FIRES).
    Lala N; Kanach CJ; Brown WD
    Clin Neurol Neurosurg; 2022 Jun; 217():107247. PubMed ID: 35483186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined immunoglobulin and plasmapheresis treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES).
    Coban Y; Akbas Y; Tuncer GO; Koker A; Koker SA
    Transfus Apher Sci; 2022 Dec; 61(6):103498. PubMed ID: 35879215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anakinra and tocilizumab in the chronic phase of febrile infection-related epilepsy syndrome (FIRES): Effectiveness and safety from a case-series.
    Aledo-Serrano A; Hariramani R; Gonzalez-Martinez A; Álvarez-Troncoso J; Toledano R; Bayat A; Garcia-Morales I; Becerra JL; Villegas-Martínez I; Beltran-Corbellini A; Gil-Nagel A
    Seizure; 2022 Aug; 100():51-55. PubMed ID: 35759951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional deficiency in endogenous interleukin-1 receptor antagonist in patients with febrile infection-related epilepsy syndrome.
    Clarkson BDS; LaFrance-Corey RG; Kahoud RJ; Farias-Moeller R; Payne ET; Howe CL
    Ann Neurol; 2019 Apr; 85(4):526-537. PubMed ID: 30779222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome.
    Specchio N; Pietrafusa N
    Dev Med Child Neurol; 2020 Aug; 62(8):897-905. PubMed ID: 32372459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Permanent loss of independence in adult febrile-infection-related epilepsy syndrome survivors: an underestimated and unsolved challenge.
    Nass RD; Taube J; Bauer T; Rüber T; Surges R; Helmstaedter C
    Eur J Neurol; 2021 Sep; 28(9):3061-3071. PubMed ID: 34091969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extinguishing Febrile Infection-Related Epilepsy Syndrome: Pipe Dream or Reality?
    Payne ET; Koh S; Wirrell EC
    Semin Neurol; 2020 Apr; 40(2):263-272. PubMed ID: 32185792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Super refractory status in a case of Febrile Infection-Related Epilepsy Syndrome due to hemophagocytic lymphocytic histiocytosis.
    Meenakshi-Sundaram S; Sankaranarayanan M; Jeyaraman M; Ayyappan C; Karthik SN; Pandi S
    Epilepsia Open; 2021 Mar; 6(1):22-27. PubMed ID: 33681644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Febrile infection-related epilepsy syndrome with claustrum lesion: an underdiagnosed inflammatory encephalopathy.
    Bai L; Di W; Xu Z; Liu B; Lin N; Fan S; Ren H; Lu Q; Wang J; Guan H;
    Neurol Sci; 2024 Jul; 45(7):3411-3419. PubMed ID: 38342839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabidiol in the acute phase of febrile infection-related epilepsy syndrome (FIRES).
    Fetta A; Crotti E; Campostrini E; Bergonzini L; Cesaroni CA; Conti F; Di Pisa V; Gentile V; Mondardini MC; Vezzoli C; Giordano L; Cordelli DM
    Epilepsia Open; 2023 Jun; 8(2):685-691. PubMed ID: 37042946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical presentation of new onset refractory status epilepticus in children (the pSERG cohort).
    Sculier C; Barcia Aguilar C; Gaspard N; Gaínza-Lein M; Sánchez Fernández I; Amengual-Gual M; Anderson A; Arya R; Burrows BT; Brenton JN; Carpenter JL; Chapman KE; Clark J; Gaillard WD; Glauser TA; Goldstein JL; Goodkin HP; Gorman M; Lai YC; McDonough TL; Mikati MA; Nayak A; Peariso K; Riviello J; Rusie A; Sperberg K; Stredny CM; Tasker RC; Tchapyjnikov D; Vasquez A; Wainwright MS; Wilfong AA; Williams K; Loddenkemper T;
    Epilepsia; 2021 Jul; 62(7):1629-1642. PubMed ID: 34091885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Claustrum Sign in Febrile Infection-Related Epilepsy Syndrome (FIRES).
    Di Dier K; Dekesel L; Dekeyzer S
    J Belg Soc Radiol; 2023; 107(1):45. PubMed ID: 37396965
    [No Abstract]   [Full Text] [Related]  

  • 35. A retrospective study of 92 children with new-onset refractory status epilepticus.
    Wu J; Lan X; Yan L; Hu Y; Hong S; Jiang L; Chen J
    Epilepsy Behav; 2021 Dec; 125():108413. PubMed ID: 34794014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myoclonic super-refractory status epilepticus with favourable evolution in a teenager with FIRES: Is the association of vagus nerve stimulation and cannabidiol effective?
    Bonardi CM; Furlanis GM; Toldo I; Guarrera B; Luisi C; Pettenazzo A; Nosadini M; Boniver C; Sartori S; Landi A
    Brain Dev; 2023 May; 45(5):293-299. PubMed ID: 36725381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropathology of New-Onset Refractory Status Epilepticus (NORSE).
    Hanin A; Cespedes J; Huttner A; Strelnikov D; Gopaul M; DiStasio M; Vezzani A; Hirsch LJ; Aronica E
    J Neurol; 2023 Aug; 270(8):3688-3702. PubMed ID: 37079033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Febrile Infection-Related Epilepsy Syndrome (FIRES): A Literature Review and Case Study.
    Fox K; Wells ME; Tennison M; Vaughn B
    Neurodiagn J; 2017; 57(3):224-233. PubMed ID: 28898171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Etiology is the key determinant of neuroinflammation in epilepsy: Elevation of cerebrospinal fluid cytokines and chemokines in febrile infection-related epilepsy syndrome and febrile status epilepticus.
    Kothur K; Bandodkar S; Wienholt L; Chu S; Pope A; Gill D; Dale RC
    Epilepsia; 2019 Aug; 60(8):1678-1688. PubMed ID: 31283843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Febrile infection-related epilepsy syndrome (FIRES): therapeutic complications, long-term neurological and neuroimaging follow-up.
    Lee HF; Chi CS
    Seizure; 2018 Mar; 56():53-59. PubMed ID: 29453111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.